Practice and consideration of master protocol in clinical trials
Tumor Discovery · 2023
DOI: 10.36922/td.342 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Tumor Discovery, 2023. Verfasst von Jiali Song und 11 weiteren Autor:innen.
Abstract (Originalsprache)
There is considerable interest in expediting late-stage therapy development by efficiently conducting trial designs that encompass multiple therapies or multiple subpopulations simultaneously within a unified protocol. Such trial designs are referred to as master protocols, with specific designs characterized by the terms umbrella, basket, or platform. These designs, in contrast to the traditional trial designs, are full of complexity. What factors should be considered in designing a trial ensuring the safety of human subjects and demonstrating the efficacy of new therapy? This paper overviews the master protocol framework, comprehensively unifies the definitions, and illustrates essential design elements of representative example trials conducted in drugs and medical devices. Besides, to understand the master protocols deeply, it is also a need to summarize the commonly-used types of master protocols in various disease and treatment fields, along with the reasons for these phenomena by analyzing the characteristics of the diseases, the mechanism of therapeutic products, and the principles of various types of master protocols. Finally, we also propose practical considerations, including the design, ethical, statistics, and funding considerations that arise from implementing complex master protocols. This information serves to guide practitioners in designing more effective trials and identifying potentially valuable therapies.
Zitieren
APA
Song, J., Rong, Z., Zhong, X., Lu, Y., Huang, J., Yu, Y., Liu, Z., Quan, X., Chen, N., Li, K., Sun, F., & Hou, Y. (2023). Practice and consideration of master protocol in clinical trials. Tumor Discovery. https://doi.org/10.36922/td.342
Vancouver
Song J, Rong Z, Zhong X, Lu Y, Huang J, Yu Y, et al. Practice and consideration of master protocol in clinical trials. Tumor Discovery. 2023. doi:10.36922/td.342
BibTeX
@article{Song2023,
author = {Song, Jiali and Rong, Zhiwei and Zhong, Xinwen and Lu, Yuhong and Huang, Jike and Yu, Yipei and Liu, Zhilin and Quan, Xuyuan and Chen, Nana and Li, Kang and Sun, Fengyu and Hou, Yan},
title = {Practice and consideration of master protocol in clinical trials},
journal = {Tumor Discovery},
year = {2023},
doi = {10.36922/td.342}
}
EUVIMED